These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 3775630
41. Clinical comparison of metrizamide and iopamidol for myelography. Turski PA, Sackett JF, Gentry LR, Strother CM, Matozzi F. AJNR Am J Neuroradiol; 1983; 4(3):309-11. PubMed ID: 6410729 [Abstract] [Full Text] [Related]
42. Iotrol, a new myelographic agent: 2. Comparative electroencephalographic evaluation by spectrum analysis. Sovak M, Ranganathan R, Kerber CW, Bickford R, Alksne JF. AJNR Am J Neuroradiol; 1983; 4(3):319-22. PubMed ID: 6410733 [Abstract] [Full Text] [Related]
43. Iohexol vs. iopamidol for myelography. Lamb JT. Invest Radiol; 1985; 20(1 Suppl):S37-43. PubMed ID: 3882615 [Abstract] [Full Text] [Related]
44. [Comparison of the side-effects of iohexol and metrizamide in lumbar myelography/radiculography]. Lesak F. Ugeskr Laeger; 1986 May 12; 148(20):1206-8. PubMed ID: 3727099 [No Abstract] [Full Text] [Related]
45. [Comparative study of iohexol and iopamidol as cardioangiographic contrast media]. Esplugas E, Jara F, Sala J, Cequier A. Rev Esp Cardiol; 1990 Feb 12; 43(2):84-6. PubMed ID: 2326538 [Abstract] [Full Text] [Related]
46. Iohexol 300 mg I/ml versus Iopamidol 300 mg I/ml for cervical myelography double blind trial. Valk J, Crezée FC, de Slegte RG, Hazenberg GJ, Wolbers J, Bach-Gansmo T. Neuroradiology; 1987 Feb 12; 29(2):202-5. PubMed ID: 3295584 [No Abstract] [Full Text] [Related]
47. Absence status epilepticus resulting from metrizamide and omnipaque myelography. Ahmed I, Pepple R, Jones RP. Clin Electroencephalogr; 1988 Jan 12; 19(1):37-42. PubMed ID: 3396204 [Abstract] [Full Text] [Related]
49. Sex and age related differences in postmyelographic adverse reactions. A prospective study of 1765 myelographies. Maly P. Neuroradiology; 1989 Jan 12; 31(4):331-5. PubMed ID: 2797425 [Abstract] [Full Text] [Related]
50. Psychopathometric demonstration and quantification of mental disturbances following myelography with metrizamide and iopamidol. Galle G, Huk W, Arnold K. Neuroradiology; 1984 Jan 12; 26(3):229-33. PubMed ID: 6738855 [Abstract] [Full Text] [Related]
51. [Adverse reactions during ascending cervical myelography using iopamidol and metrizamide--a double-blind study]. Bockenheimer S, Eichenlaub H. Rontgenpraxis; 1986 May 12; 39(5):171-4. PubMed ID: 3523789 [No Abstract] [Full Text] [Related]
52. [A randomized, double-blind clinical trial of 2 nonionic contrast media for myelography]. Lovrencić M, Klanfar Z, Jakovac I. Lijec Vjesn; 1986 Apr 12; 108(4):141-6. PubMed ID: 3520199 [No Abstract] [Full Text] [Related]
53. Routine bed rest is unnecessary after cervical myelography. Macpherson P, Teasdale E. Neuroradiology; 1985 Apr 12; 27(3):214-6. PubMed ID: 4010919 [Abstract] [Full Text] [Related]
54. A comparison of iopamidol and iohexol in cerebral angiography. Pelz DM, Fox AJ, Viñuela F, Lylyk P. AJNR Am J Neuroradiol; 1988 Apr 12; 9(6):1163-6. PubMed ID: 3143239 [Abstract] [Full Text] [Related]
55. Myelography with lopamidol. Lamb JT, Holland IM. AJNR Am J Neuroradiol; 1983 Apr 12; 4(3):851-3. PubMed ID: 6410871 [Abstract] [Full Text] [Related]
56. [Use of non-ionogenic contrast media for myelography]. Sviridov NK, Popova ZP, Varfolomeeva VN. Zh Vopr Neirokhir Im N N Burdenko; 1984 Apr 12; (4):50-3. PubMed ID: 6388202 [No Abstract] [Full Text] [Related]
57. [Tolerability of nonionic contrast media--results of a multicenter double blind study]. Schmiedel E. Aktuelle Radiol; 1992 May 12; 2(3):148-52. PubMed ID: 1610929 [Abstract] [Full Text] [Related]
58. Clinical experience with iomeprol in myelography and myelo-CT: clinical pharmacology and double-blind comparisons with iopamidol, iohexol, and iotrolan. Katayama H, Heneine N, van Gessel R, Taroni P, Spinazzi A. Invest Radiol; 2001 Jan 12; 36(1):22-32. PubMed ID: 11176258 [Abstract] [Full Text] [Related]